Ingo Schäfer

Ingo Schäfer

Auto-generated profile, based on publicly available information

Ingo Schäfer

Zentrum für Interdisziplinäre Suchtforschung (ZIS) der Universität Hamburg, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2017 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
AKAntje Krüger-Gottschalk
Antje Krüger-Gottschalk
CKChristine Knaevelsrud
Christine Knaevelsrud
HRHeinrich Rau
Heinrich Rau
ADAnne Dyer
Anne Dyer
ISIngo Schäfer
Ingo Schäfer
TEThomas Ehring
Thomas Ehring
The Posttraumatic Stress Disorder (PTSD) Checklist (PCL, now PCL-5) has recently been revised to reflect the new diagnostic criteria of the disorder. A clinical sample of trauma-exposed individuals (N = 352) was assessed with the Clinician Administered PTSD Scale for DSM-5 (CAPS-5) and the PCL-5. Internal consistencies and test-retest reliability were computed. To investigate diagnostic accuracy, we calculated receiver operating curves. Confirmatory factor analyses (CFA) were performed to analyze the structural validity. Results showed high internal consistency (α = .95), high test-retest reliability (r = .91) and a high correlation with the total severity score of the CAPS-5, r = .77. In addition, the recommended cutoff of 33 on the PCL-5 showed high diagnostic accuracy when compared to the diagnosis established by the CAPS-5. CFAs comparing the DSM-5 model with alternative models (the three-factor solution, the dysphoria, anhedonia, externalizing behavior and hybrid model) to account for the structural validity of the PCL-5 remained inconclusive. Overall, the findings show that the German PCL-5 is a reliable instrument with good diagnostic accuracy. However, more research evaluating the underlying factor structure is needed.

30 September 2011 in Dialogues in clinical neuroscience
Verified
Journal Article
Open access
ISIngo Schäfer
Ingo Schäfer
HFHelen L. Fisher
Helen L. Fisher
In the last decade, a substantial number of population-based studies have suggested that childhood trauma is a risk factor for psychosis. In several studies, the effects held after adjusting for a wide range of potentially confounding variables, including genetic liability for psychosis. Less is kno …

3 May 2022 in European Journal of Psychotraumatology
Verified
Journal Article
Open access
NRNeil P. Roberts
Neil P. Roberts
DLDr. Annett Lotzin
Dr. Annett Lotzin
ISIngo Schäfer
Ingo Schäfer
The psychological treatment of comorbid post-traumatic stress disorder (PTSD) and substance use disorder (SUD) is clinically challenging, and outcomes are often poor.This paper describes a systemat... Antecedentes: El tratamiento psicológico del trastorno de estrés postraumático (TEPT) comórbido con trastorno por uso de sustancias (TUS) es un desafío clínico y los resultados suelen ser deficient... 背景: 创伤后应激障碍 (PTSD) 和物质使用障碍 (SUD) 共病的心理治疗在临床上具有挑战性,结果通常很差。目的: 本文描述了一项旨在确定一些针对成人和青少年已建立的心理方法相较于单独 SUD 干预或其他积极方法的当前疗效的系统综述和元分析,遵循了预注册的方案。方法: 本综述遵循 PRISMA 和 Cochrane 协作指南。所有作者均使用 Cochrane 标准进行数据提取和误差风险...

28 June 2021 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
MWMaxi Weber
Maxi Weber
SSSarah Schumacher
Sarah Schumacher
WHWiebke Hannig
Wiebke Hannig
JBJürgen Barth
Jürgen Barth
DLDr. Annett Lotzin
Dr. Annett Lotzin
BKBirgit Kleim
Birgit Kleim
Several types of psychological treatment for posttraumatic stress disorder (PTSD) are considered well established and effective, but evidence of their long-term efficacy is limited. This systematic review and meta-analysis aimed to investigate the long-term outcomes across psychological treatments for PTSD. MEDLINE, Cochrane Library, PTSDpubs, PsycINFO, PSYNDEX, and related articles were searched for randomized controlled trials with at least 12 months of follow-up. Twenty-two studies (N = 2638) met inclusion criteria, and 43 comparisons of cognitive behavioral therapy (CBT) were available at follow-up. Active treatments for PTSD yielded large effect sizes from pretest to follow-up and a small controlled effect size compared with non-directive control groups at follow-up. Trauma-focused treatment (TFT) and non-TFT showed large improvements from pretest to follow-up, and effect sizes did not significantly differ from each other. Active treatments for comorbid depressive symptoms revealed small to medium effect sizes at follow-up, and improved PTSD and depressive symptoms remained stable from treatment end to follow-up. Military personnel, low proportion of female patients, and self-rated PTSD measures were associated with decreased effect sizes for PTSD at follow-up. The findings suggest that CBT for PTSD is efficacious in the long term. Future studies are needed to determine the lasting efficacy of other psychological treatments and to confirm benefits beyond 12-month follow-up.

1 January 2021 in European Journal of Psychotraumatology
Verified
Journal Article
Open access
DLDr. Annett Lotzin
Dr. Annett Lotzin
LKLinda Krause
Linda Krause
EAElena Acquarini
Elena Acquarini
DADean Ajdukovic
Dean Ajdukovic
VAVittoria Ardino
Vittoria Ardino
ACADJUST Study Consortium
ADJUST Study Consortium
Background: The COVID-19 pandemic exposes individuals to multiple stressors, such as quarantine, physical distancing, job loss, risk of infection, and loss of loved ones. Such a complex array of stressors potentially lead to symptoms of adjustment disorder. Objective: This cross-sectional exploratory study examined relationships between risk and protective factors, stressors, and symptoms of adjustment disorder during the first year of the COVID-19 pandemic. Methods: Data from the first wave of the European Society of Traumatic Stress Studies (ESTSS) longitudinal ADJUST Study were used. N = 15,563 participants aged 18 years and above were recruited in eleven countries (Austria, Croatia, Georgia, Germany, Greece, Italy, Lithuania, the Netherlands, Poland, Portugal, and Sweden) from June to November 2020. Associations between risk and protective factors (e.g. gender, diagnosis of a mental health disorder), stressors (e.g. fear of infection, restricted face-to-face contact), and symptoms of adjustment disorder (ADNM-8) were examined using multivariate linear regression. Results: The prevalence of self-reported probable adjustment disorder was 18.2%. Risk factors associated with higher levels of symptoms of adjustment disorder were female gender, older age, being at risk for severe COVID-19 illness, poorer general health status, current or previous trauma exposure, a current or previous mental health disorder, and longer exposure to COVID-19 news. Protective factors related to lower levels of symptoms of adjustment disorder were higher income, being retired, and having more face-to-face contact with loved ones or friends. Pandemic-related stressors associated with higher levels of symptoms of adjustment disorder included fear of infection, governmental crisis management, restricted social contact, work-related problems, restricted activity, and difficult housing conditions. Conclusions: We identified stressors, risk, and protective factors that may help identify individuals at higher risk for adjustment disorder.

19 February 2019 in European Journal of Psychotraumatology
Verified
Journal Article
Open access
ISIngo Schäfer
Ingo Schäfer
ALAnnett Lotzin
Annett Lotzin
PHPhilipp Hiller
Philipp Hiller
SSSusanne Sehner
Susanne Sehner
MDMartin Driessen
Martin Driessen
JGJohanna Grundmann
Johanna Grundmann
Background: Co-occurring posttraumatic stress disorder (PTSD) and substance use disorders (SUD) are associated with a more severe course and worse outcome than either disorder alone. In Europe, few treatments have been evaluated for PTSD and SUD. Seeking Safety, a manualized, integrated, cognitive-behavioural treatment, has been shown to be effective in studies in the USA. Objective: To test the efficacy of Seeking Safety plus treatment as usual (TAU) in female outpatients with PTSD and SUD compared to Relapse Prevention Training (RPT) plus TAU and TAU alone. Method: In five German study centres a total of N = 343 women were randomized into one of the three study conditions. PTSD severity (primary outcome), substance use, depression and emotion dysregulation (secondary outcomes) were assessed at baseline, post-treatment, as well as at three months and six months post-treatment. Results: Treatment participants attended M = 6.6 sessions (Seeking Safety) and M = 6.1 sessions (RPT). In an intent-to-treat analysis, Seeking Safety plus TAU, RPT plus TAU and TAU alone showed comparable decreases in PTSD severity over the course of the study. Seeking Safety plus TAU showed superior efficacy to TAU alone on depression and emotion regulation and RPT plus TAU was more effective than TAU alone on number of substance-free days and alcohol severity. Minimum-dose analyses suggest additional effects of both programmes among participants who attended at least eight group sessions. Conclusions: With respect to PTSD symptoms, a brief dose of Seeking Safety and RPT in addition to TAU was not superior to TAU alone in women with PTSD and SUD. However, Seeking Safety and RPT showed greater reductions than TAU alone in other domains of psychopathology and substance use outcomes respectively. Future studies should investigate further variables, such as what aspects of each treatment appeal to particular patients and how best to disseminate them.